Co-Diagnostics Inc (CODX)
$17.47 0.72 (3.96%)
17:09 EDT CODX Stock Quote Delayed 30 Minutes
Previous Close $18.19
Market Cap 215.34M
PE Ratio -28.47
Volume (Avg. Vol.) 1.90M
Day's Range 17.45 - 18.70
52-Week Range 0.85 - 29.72
Dividend & Yield N/A (N/A)
CODX Stock Predictions, Articles, and Co-Diagnostics Inc News
- From InvestorPlace
- From the Web
Co-Diagnostics will be on the move over the next week. Don't confuse a technical trade for a strong long-term investment case in CODX stock.
CODX stock will start to tumble back to earth as more competitors enter the testing space, and the impact of Covid-19 subsides.
These seven A- and B-rated names are some of the top risky stocks to buy for enterprising investors. Here's what you should know about each company.
CODX stock took a hit as economic indicators suggested a sooner-than-expected recovery. But don’t completely ignore shares just yet.
The price target for CODX stock has been raised, but the testing-kit leader should easily clear the bar. More upside ahead.
The rush to develop a COVID-19 diagnostic test has pushed CODX stock to new highs. But investors may need more scientific evidence to stay in the shares long-term.
CODX stock could continue delivering upside if its novel coronavirus test kit proves accurate and vaccines take awhile to come to market.
From an investment standpoint, I’m always thinking about my options. I don’t necessarily have to invest in CODX stock because there are other potential options available, ones probably safer in the grand scheme of things.
The fear of missing out is a real stock price driver. Add to it the fear of the virus and you get unlimited upside potential for CODX stock.
There's evidence that Co-Diagnostics' test is not as accurate as many of its competitors' offerings. That makes CODX stock quite risky.
Co-Diagnostics may be worth much more than today's price. CODX stock could be worth two or three times more, under certain estimates.
Co-Diagnostics benefits from the quantity and quality of its test kits. This means CODX stock should long be one of investors' favorites.
Biotech stocks are in the spotlight in 2020, with the race to develop testing, treatment and a vaccine for Covid-19 driving rapid growth.
We're starting to see some light at the end of the coronavirus tunnel, and investors are looking at stocks to buy for a post-crisis bump.
Co-Diagnostics has seen its business explode because of the coronavirus pandemic and CODX stock is up over 1800% so far in 2020.
The last thing you need in your portfolio is a drastically volatile asset. Avoid CODX stock in both short- and long-term trades.
Co-Diagnostics stock has emerged as a big winner from Covid-19. Testing for novel viruses may make it a long-term winner in the new normal.
Co-Diagnostics says its coronavirus tests are 100% accurate in tests in three countries, making CODX stock a smart play.
Every investor in CSW Industrials, Inc. (NASDAQ:CSWI) should be aware of the most powerful shareholder groups. Insiders often own a large chunk of younger, smaller, companies while huge companies tend<div><a class="permalink" href="https://simplywall.st/stocks/us/capital-goods/nasdaq-cswi/csw-industrials/news/what-kind-of-shareholder-owns-most-csw-industrials-inc-nasdaqcswi-stock/">Read More...</a></div>
Today we’ll look at CSW Industrials, Inc. (NASDAQ:CSWI) and reflect on its potential as an investment. Specifically, we’ll consider its Return On Capital Employed (ROCE), since that will give us<div><a class="permalink" href="https://simplywall.st/stocks/us/capital-goods/nasdaq-cswi/csw-industrials/news/why-we-like-csw-industrials-inc-s-nasdaqcswi-20-return-on-capital-employed/">Read More...</a></div>
From Market News Video
A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both..
This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios). To keep it practical, we’ll show how CSW Industrials, Inc.’s (NASDAQ:CSWI)<div><a class="permalink" href="https://simplywall.st/stocks/us/capital-goods/nasdaq-cswi/csw-industrials/news/should-you-be-tempted-to-sell-csw-industrials-inc-nasdaqcswi-because-of-its-p-e-ratio/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader